Galantamine hydrobromide

Galantamine Hydrobromide is the hydrobromide salt form of galantamine, a tertiary alkaloid obtained synthetically or naturally from the bulbs and flowers of Narcissus and several other genera of the Amaryllidaceae family with anticholinesterase and neurocognitive-enhancing activities. Galantamine competitively and reversibly inhibits acetylcholinesterase, thereby increasing the concentration and enhancing the action of acetylcholine (Ach). Additionally, galantamine is a ligand for nicotinic acetylcholine receptors, which may increase the presynaptic release of Ach and activate postsynaptic receptors. This agent may improve neurocognitive function in mild and moderate Alzheimer’ s disease and may reduce abstinence-induced cognitive symptoms that promote smoking relapse. It is grouped under the following drug class(es): Neurotransmitter agents. Its therapeutic use is listed as central nervous system (CNS) agents. The directory classifies it as a commercial API with a natural source/manufacturing origin. Other names for this substance include Nivalin, GalantaMind and Nivalin. Its PubChem CID is 121587.

CAS No 1953-04-04
Molecular Formula C17H22BrNO3
Molecular Weight 368.3 g/mol
Synonyms (1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol;hydrobromide

Frequently Asked Questions